Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Petersen, Tianna
RESOLUTION, NCT04417257: Study of LAU-7b for the Treatment of COVID-19 Disease in Adults	Completed	2/3	125	Canada, US	LAU-7b, fenretinide, Placebo oral capsule	Laurent Pharmaceuticals Inc.	COVID-19 Disease	02/24	05/24
NCT03993106 / 2017-001828-22: A Study of sEphB4-HSA in Kaposi Sarcoma	Recruiting	2	65	US	sEphB4-HSA	Vasgene Therapeutics, Inc	Kaposi Sarcoma	12/24	06/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Petersen, Tianna
RESOLUTION, NCT04417257: Study of LAU-7b for the Treatment of COVID-19 Disease in Adults	Completed	2/3	125	Canada, US	LAU-7b, fenretinide, Placebo oral capsule	Laurent Pharmaceuticals Inc.	COVID-19 Disease	02/24	05/24
NCT03993106 / 2017-001828-22: A Study of sEphB4-HSA in Kaposi Sarcoma	Recruiting	2	65	US	sEphB4-HSA	Vasgene Therapeutics, Inc	Kaposi Sarcoma	12/24	06/25